What information and support can I give to my patients?
This is promotional content, intended for UK healthcare professionals only. This webpage has been developed and funded by the Bristol-Myers Squibb / Pfizer Alliance.
Click here to view ELIQUIS® (apixaban) prescribing and adverse event reporting information.
As recommended by NICE, all patients receiving anticoagulation treatment should receive verbal and written information about:1
how to use anticoagulants
how long to take anticoagulants
possible side effects of anticoagulants and what to do if these occur
how other medications, foods and alcohol can affect oral anticoagulation treatment
any monitoring needed for their anticoagulant treatment
how anticoagulants may affect their dental treatment
taking anticoagulants if they are planning pregnancy or become pregnant*
how anticoagulants may affect activities such as sports and travel
when and how to seek medical help
*Avoid the use of apixaban in pregnancy and breastfeeding.2
To assist you in supporting your patients with DVT / PE, who are on apixaban, and to help them understand more about their condition and their anticoagulation medicine, we have created a range of resources and support tools, available at ELIQUIS.co.uk and displayed below.
Adverse events should be reported. Reporting forms and information can be found via United Kingdom – The yellow card scheme at www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Bristol-Myers Squibb via email@example.com or 0800 731 1736 (United Kingdom).
This link takes you to a third party website that is part of the Bristol-Myers Squibb Group and Pfizer Group. The Alliance (Bristol Myers Squibb Group and Pfizer Group) recommends that you check whether it is suitable for you as per its intended audience and the applicable laws and regulations before accessing it. If you wish to continue, click ‘Continue’, otherwise click ‘Stay on this site’.